SPRY1
Protein sprouty homolog 1
Also known as: hSPRY1, SPY1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O43609
- Gene
- SPRY1
- Ensembl
- ENSG00000164056
- Chromosome
- 4
- Canonical length
- 319 aa
- Protein class
- Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Golgi apparatus,Cytosol
OverviewNCBI Gene
Involved in negative regulation of fibroblast growth factor receptor signaling pathway. Located in Golgi apparatus; cytosol; and nucleoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
319 residues, UniProt reviewed canonical sequence.
>O43609|SPRY1
1 MDPQNQHGSG SSLVVIQQPS LDSRQRLDYE REIQPTAILS LDQIKAIRGS NEYTEGPSVV
61 KRPAPRTAPR QEKHERTHEI IPINVNNNYE HRHTSHLGHA VLPSNARGPI LSRSTSTGSA
121 ASSGSNSSAS SEQGLLGRSP PTRPVPGHRS ERAIRTQPKQ LIVDDLKGSL KEDLTQHKFI
181 CEQCGKCKCG ECTAPRTLPS CLACNRQCLC SAESMVEYGT CMCLVKGIFY HCSNDDEGDS
241 YSDNPCSCSQ SHCCSRYLCM GAMSLFLPCL LCYPPAKGCL KLCRRCYDWI HRPGCRCKNS
301 NTVYCKLESC PSRGQGKPSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SPRY1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.58
- Highest tissue expression
- 225 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 225 nTPM
- breast: 149 nTPM
- blood vessel: 109 nTPM
- thyroid gland: 89 nTPM
- fallopian tube: 84 nTPM
- gallbladder: 79 nTPM
Single-cell type
- vascular endothelial cells: 501 nCPM
- leydig cells: 475 nCPM
- myosatellite cells: 328 nCPM
- mesothelial cells: 240 nCPM
- innate lymphoid cells: 235 nCPM
- pituicytes/fscs: 217 nCPM
Immune cell
- naive B-cell: 61 nTPM
- MAIT T-cell: 33 nTPM
- memory B-cell: 30 nTPM
- NK-cell: 14 nTPM
- memory CD8 T-cell: 9.2 nTPM
- eosinophil: 6.5 nTPM
Brain region
- choroid plexus: 53 nTPM
- cerebral cortex: 15 nTPM
- hypothalamus: 15 nTPM
- basal ganglia: 14 nTPM
- cerebellum: 13 nTPM
- hippocampal formation: 12 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SPRY1.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 72 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.22
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.95
- DepMap mean gene effect
- 0.13
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- animal organ development
- bud elongation involved in lung branching
- epithelial to mesenchymal transition involved in cardiac fibroblast development
- ERK1 and ERK2 cascade
- establishment of mitotic spindle orientation
- metanephros development
- negative regulation of cell population proliferation
- negative regulation of epithelial to mesenchymal transition
- negative regulation of ERK1 and ERK2 cascade
- negative regulation of fibroblast growth factor receptor signaling pathway
- negative regulation of lens fiber cell differentiation
- negative regulation of neurotrophin TRK receptor signaling pathway
- negative regulation of Ras protein signal transduction
- negative regulation of transforming growth factor beta receptor signaling pathway
- organ induction
- ureteric bud development
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SPRY1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SPRY1 as an antibody target. Whether an autoantibody or antibody against SPRY1 could matter depends on whether native SPRY1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SPRY1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SPRY1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...